98 related articles for article (PubMed ID: 13575837)
1. Urinary excretion of 17-ketosteroids in Kala-azar.
CHATTERJI A; SEN GUPTA PC
J Indian Med Assoc; 1958 Jul; 31(1):11-3. PubMed ID: 13575837
[No Abstract] [Full Text] [Related]
2. Evaluation of renal function in human visceral leishmaniasis (kala-azar): a prospective study on 50 patients from Brazil.
Lima Verde FA; Lima Verde FA; Lima Verde IA; Silva Junior GB; Daher EF; Lima Verde EM
J Nephrol; 2007; 20(4):430-6. PubMed ID: 17879209
[TBL] [Abstract][Full Text] [Related]
3. Pattern of D-xylose excretion test in kala-azar patients.
Hati AK; Bhattacharyya J; Mukherjee H; Ghosh S; Das DC
J Indian Med Assoc; 1993 Oct; 91(10):267. PubMed ID: 8308312
[No Abstract] [Full Text] [Related]
4. Evaluation of a urinary antigen-based latex agglutination test in the diagnosis of kala-azar in eastern Nepal.
Rijal S; Boelaert M; Regmi S; Karki BM; Jacquet D; Singh R; Chance ML; Chappuis F; Hommel M; Desjeux P; Van der Stuyft P; Le Ray D; Koirala S
Trop Med Int Health; 2004 Jun; 9(6):724-9. PubMed ID: 15189464
[TBL] [Abstract][Full Text] [Related]
5. Post-kala-azar dermal leishmaniasis and visceral leishmaniasis in a child--or is it para-kala-azar dermal leishmaniasis?
Mendiratta V; Chander R
Int J Dermatol; 2009 Sep; 48(9):1027-8. PubMed ID: 19703001
[No Abstract] [Full Text] [Related]
6. Orally effective drugs for kala-azar (visceral leishmaniasis): focus on miltefosine and sitamaquine.
Sangraula H; Sharma KK; Rijal S; Dwivedi S; Koirala S
J Assoc Physicians India; 2003 Jul; 51():686-90. PubMed ID: 14621038
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of visceral leishmaniasis associated with the behaviors of the people in rural areas.
Shah H
JNMA J Nepal Med Assoc; 2005; 44(160):116-20. PubMed ID: 16751812
[TBL] [Abstract][Full Text] [Related]
8. The epidemiology of visceral leishmaniasis and asymptomatic leishmanial infection in a highly endemic Bangladeshi village.
Bern C; Haque R; Chowdhury R; Ali M; Kurkjian KM; Vaz L; Amann J; Wahed MA; Wagatsuma Y; Breiman RF; Williamson J; Secor WE; Maguire JH
Am J Trop Med Hyg; 2007 May; 76(5):909-14. PubMed ID: 17488915
[TBL] [Abstract][Full Text] [Related]
9. An unusual presentation of post-kala-azar dermal leishmaniasis.
Ramesh V; Kumar J; Salotra P
Trop Doct; 2007 Jul; 37(3):172-3. PubMed ID: 17716510
[TBL] [Abstract][Full Text] [Related]
10. Visceral leishmaniasis (kala-azar) and pregnancy.
Figueiró-Filho EA; Duarte G; El-Beitune P; Quintana SM; Maia TL
Infect Dis Obstet Gynecol; 2004; 12(1):31-40. PubMed ID: 15460194
[TBL] [Abstract][Full Text] [Related]
11. Kala-azar (visceral Leishmaniasis) from Khotang.
Joshi S; Bajracharya BL; Baral MR
Kathmandu Univ Med J (KUMJ); 2006; 4(2):232-4. PubMed ID: 18603904
[TBL] [Abstract][Full Text] [Related]
12. Post kala-azar dermal leishmaniasis (PKDL): a first case report from Nepal.
Karki P; Koirala S; Parija SC; Sethi M; Das ML
Indian J Pathol Microbiol; 2003 Apr; 46(2):214-5. PubMed ID: 15022913
[TBL] [Abstract][Full Text] [Related]
13. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis, or a rare presentation of visceral leishmaniasis with extensive skin manifestations.
Ramesh V
Int J Dermatol; 2007 Dec; 46(12):1326. PubMed ID: 18173544
[No Abstract] [Full Text] [Related]
14. Ulcerative post-kala azar mucosal leishmaniasis masquerading as a carcinoma--a case report.
Toran KC; Sah SP; Joshi A; Rani S
Indian J Pathol Microbiol; 2003 Jul; 46(3):487-9. PubMed ID: 15025319
[TBL] [Abstract][Full Text] [Related]
15. Present situation of vector-control management in Bangladesh: a wake up call.
Mondal D; Alam MS; Karim Z; Haque R; Boelaert M; Kroeger A
Health Policy; 2008 Sep; 87(3):369-76. PubMed ID: 18342389
[TBL] [Abstract][Full Text] [Related]
16. [Second autochtonous case of kala-azar in Mexico. Visceral leishmaniasis].
AGUIRRE A; BIAGI F; HERNANDEZ NIETO A
Bol Med Hosp Infant Mex; 1963; 20():317-33. PubMed ID: 14011314
[No Abstract] [Full Text] [Related]
17. [Pathology of visceral leishmaniasis (kala-azar)].
ANDRADE ZA
Arq Bras Med Nav; 1958 Nov; 19(70):7347-472. PubMed ID: 13607250
[No Abstract] [Full Text] [Related]
18. Post-kala-azar dermal leishmaniasis with visceral leishmaniasis: a rare presentation.
Rijal A; Agrawal S; Agarwalla A; Agrawal A; Rijal S
Int J Dermatol; 2005 Jun; 44(6):494-6. PubMed ID: 15941439
[No Abstract] [Full Text] [Related]
19. Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis.
Das VN; Pandey K; Verma N; Lal CS; Bimal S; Topno RK; Singh D; Siddiqui NA; Verma RB; Das P
Am J Trop Med Hyg; 2009 Mar; 80(3):336-8. PubMed ID: 19270277
[TBL] [Abstract][Full Text] [Related]
20. Short communication: post-kala-azar dermal leishmaniasis--an appraisal.
Ramesh V; Singh R; Salotra P
Trop Med Int Health; 2007 Jul; 12(7):848-51. PubMed ID: 17596251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
